Xenon Pharmaceuticals

+$0.12 (+0.45%) As of 3:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XENE and other ETFs, options, and stocks.

About XENE

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions.

CEO
Ian C. Mortimer
Employees
—
Headquarters
Burnaby, British Columbia
Founded
1996

XENE Key Statistics

Market cap
1.42B
Price-Earnings ratio
—
Dividend yield
—
Average volume
466.17K
High today
$27.04
Low today
$26.12
Open price
$26.95
Volume
222.32K
52 Week high
$36.42
52 Week low
$14.65

XENE Earnings

-$0.51
-$0.34
-$0.17
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure